Cliff Asness's NVAX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 146,733 shares of Novavax, Inc. (NVAX) worth $986,045, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 162,111 shares. Largest reduction occurred in Q4 2025, reducing 32,977 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Novavax (NVAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novavax (NVAX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -32,977 | Reduce 18.35% | 146,733 | $6.72 |
| Q3 2025 | +162,111 | Add 921.14% | 179,710 | $8.67 |
| Q2 2025 | -26,828 | Reduce 60.39% | 17,599 | $6.30 |
| Q1 2025 | +21,663 | Add 95.16% | 44,427 | $6.41 |
| Q4 2024 | +4,007 | Add 21.36% | 22,764 | $8.04 |
| Q3 2024 | +18,757 | New Buy | 18,757 | $12.63 |
| Q1 2022 | -1,573 | Sold Out | 0 | $0.00 |
| Q4 2021 | +1,573 | New Buy | 1,573 | $143.04 |
| Q3 2021 | -28,679 | Sold Out | 0 | $0.00 |
| Q2 2021 | -13,101 | Reduce 31.36% | 28,679 | $212.32 |
| Q1 2021 | +854 | Add 2.09% | 41,780 | $181.31 |
| Q4 2020 | -6,598 | Reduce 13.88% | 40,926 | $111.52 |
| Q3 2020 | +25,039 | Add 111.36% | 47,524 | $108.35 |
| Q2 2020 | +22,485 | New Buy | 22,485 | $83.34 |
Cliff Asness's Novavax Investment FAQs
Cliff Asness first purchased Novavax, Inc. (NVAX) in Q2 2020, acquiring 22,485 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Novavax, Inc. (NVAX) for 14 quarters since Q2 2020.
Cliff Asness's largest addition to Novavax, Inc. (NVAX) was in Q3 2025, adding 179,710 shares worth $1.56 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 146,733 shares of Novavax, Inc. (NVAX), valued at approximately $986,045.
As of the Q4 2025 filing, Novavax, Inc. (NVAX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Novavax, Inc. (NVAX) was 179,710 shares, as reported at the end of Q3 2025.